-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2021 to Q3 2025.
- Context Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $323K, a 51.7% increase year-over-year.
- Context Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1.24M, a 42.9% increase year-over-year.
- Context Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $842K, a 21.8% decline from 2023.
- Context Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.08M, a 10.3% increase from 2022.
- Context Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $976K, a 104% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)